Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 32, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012987.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122539303, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122539303, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
glutamate receptor 2, transcript variant X3
glutamate receptor 2, transcript variant X2
glutamate receptor 2, transcript variant X4
glutamate receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane protein 144a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 144a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 144a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 144a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 144a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane protein 144a, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
electron transfer flavoprotein dehydrogenase
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
folliculin-interacting protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
folliculin-interacting protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
folliculin-interacting protein 2-like isoform X1
folliculin-interacting protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Rap guanine nucleotide exchange factor 2b, transcript variant X1
Rap guanine nucleotide exchange factor 2b, transcript variant X2
Rap guanine nucleotide exchange factor 2b, transcript variant X7
rap guanine nucleotide exchange factor 2 isoform X1
rap guanine nucleotide exchange factor 2 isoform X2
rap guanine nucleotide exchange factor 2 isoform X5
Rap guanine nucleotide exchange factor 2b, transcript variant X3
Rap guanine nucleotide exchange factor 2b, transcript variant X5
Rap guanine nucleotide exchange factor 2b, transcript variant X4
rap guanine nucleotide exchange factor 2 isoform X3
Rap guanine nucleotide exchange factor 2b, transcript variant X6
rap guanine nucleotide exchange factor 2 isoform X4
alpha-L-iduronidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-L-iduronidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
alpha-L-iduronidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
general transcription factor IIE, polypeptide 2, beta
transcription initiation factor IIE subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
deleted in malignant brain tumors 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Bardet-Biedl syndrome 7, transcript variant X1
Bardet-Biedl syndrome 7, transcript variant X2
Bardet-Biedl syndrome 7, transcript variant X3
Bardet-Biedl syndrome 7 protein isoform X1
Bardet-Biedl syndrome 7 protein isoform X2
Bardet-Biedl syndrome 7 protein isoform X3
oligosaccharyltransferase complex subunit 4 (non-catalytic)
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4
short transient receptor potential channel 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
KIAA1109 ortholog, transcript variant X1
KIAA1109 ortholog, transcript variant X7
KIAA1109 ortholog, transcript variant X6
KIAA1109 ortholog, transcript variant X8
KIAA1109 ortholog, transcript variant X9
KIAA1109 ortholog, transcript variant X10
KIAA1109 ortholog, transcript variant X5
KIAA1109 ortholog, transcript variant X4
KIAA1109 ortholog, transcript variant X11
KIAA1109 ortholog, transcript variant X3
KIAA1109 ortholog, transcript variant X2
transmembrane protein KIAA1109 homolog isoform X1
transmembrane protein KIAA1109 homolog isoform X5
transmembrane protein KIAA1109 homolog isoform X4
transmembrane protein KIAA1109 homolog isoform X6
transmembrane protein KIAA1109 homolog isoform X7
transmembrane protein KIAA1109 homolog isoform X8
transmembrane protein KIAA1109 homolog isoform X3
transmembrane protein KIAA1109 homolog isoform X2
transmembrane protein KIAA1109 homolog isoform X9
adenosine deaminase domain containing 1 (testis-specific), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine deaminase domain containing 1 (testis-specific), transcript variant X1
adenosine deaminase domain containing 1 (testis-specific), transcript variant X5
adenosine deaminase domain containing 1 (testis-specific), transcript variant X2
adenosine deaminase domain containing 1 (testis-specific), transcript variant X4
adenosine deaminase domain-containing protein 1 isoform X1
adenosine deaminase domain-containing protein 1 isoform X3
adenosine deaminase domain-containing protein 1 isoform X4
adenosine deaminase domain-containing protein 1 isoform X5
adenosine deaminase domain containing 1 (testis-specific), transcript variant X3
adenosine deaminase domain-containing protein 1 isoform X2
uncharacterized LOC122539276, transcript variant X1
uncharacterized LOC122539276, transcript variant X2
Bardet-Biedl syndrome 12, transcript variant X2
Bardet-Biedl syndrome 12 protein isoform X2
Bardet-Biedl syndrome 12, transcript variant X1
Bardet-Biedl syndrome 12 protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nudix (nucleoside diphosphate linked moiety X)-type motif 6
nucleoside diphosphate-linked moiety X motif 6
spermatogenesis associated 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatogenesis associated 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatogenesis associated 5, transcript variant X6
spermatogenesis associated 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
spermatogenesis associated 5, transcript variant X2
ATPase family protein 2 homolog isoform X1
ATPase family protein 2 homolog isoform X2
ATPase family protein 2 homolog isoform X4
ATPase family protein 2 homolog isoform X5
spermatogenesis associated 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase family protein 2 homolog isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
uncharacterized LOC122539340, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC122539340, transcript variant X5
uncharacterized LOC122539340, transcript variant X2
uncharacterized LOC122539340, transcript variant X4
uncharacterized LOC122539340, transcript variant X1
uncharacterized LOC122539340, transcript variant X3
uncharacterized LOC122539340, transcript variant X10
uncharacterized LOC122539340, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122539340, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC122539340, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122539340, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122539340, transcript variant X11
uncharacterized LOC122539340, transcript variant X14
uncharacterized LOC122539340, transcript variant X12
uncharacterized protein LOC122539340 isoform X6
uncharacterized protein LOC122539340 isoform X5
uncharacterized protein LOC122539340 isoform X2
uncharacterized protein LOC122539340 isoform X1
uncharacterized protein LOC122539340 isoform X8
uncharacterized protein LOC122539340 isoform X7
uncharacterized protein LOC122539340 isoform X4
uncharacterized protein LOC122539340 isoform X3
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X6
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X3
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X1
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X2
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X5
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X7
sprouty homolog 1, antagonist of FGF signaling (Drosophila), transcript variant X4
NEDD4 family-interacting protein 1-like, transcript variant X1
NEDD4 family-interacting protein 1-like isoform X1
NEDD4 family-interacting protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NEDD4 family-interacting protein 1-like isoform X2
ankyrin repeat domain 50, transcript variant X3
ankyrin repeat domain 50, transcript variant X1
ankyrin repeat domain 50, transcript variant X2
ankyrin repeat domain-containing protein 50
protocadherin Fat 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protocadherin Fat 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
protocadherin-10-like, transcript variant X1
protocadherin-10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E74-like factor 2a (ets domain transcription factor), transcript variant X3
E74-like factor 2a (ets domain transcription factor), transcript variant X2
E74-like factor 2a (ets domain transcription factor), transcript variant X1
E74-like factor 2a (ets domain transcription factor), transcript variant X4
ETS-related transcription factor Elf-2a isoform X3
ETS-related transcription factor Elf-2a isoform X2
ETS-related transcription factor Elf-2a isoform X1
ETS-related transcription factor Elf-2a isoform X4
uncharacterized LOC122539353, transcript variant X3
uncharacterized LOC122539353, transcript variant X5
uncharacterized LOC122539353, transcript variant X4
uncharacterized LOC122539353, transcript variant X1
uncharacterized LOC122539353, transcript variant X2
mitochondria localized glutamic acid rich protein a, transcript variant X2
mitochondria localized glutamic acid rich protein a, transcript variant X1
uncharacterized protein mgarpa isoform X2
uncharacterized protein mgarpa isoform X1
NADH:ubiquinone oxidoreductase subunit C1
NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial
N-alpha-acetyltransferase 15, NatA auxiliary subunit a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
N-alpha-acetyltransferase 15, NatA auxiliary subunit a, transcript variant X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC541425 homolog, transcript variant X2
uncharacterized protein LOC541425 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein zgc:113425 isoform X1
uncharacterized protein LOC541425 homolog, transcript variant X3
uncharacterized protein zgc:113425 isoform X2
SET domain containing 7, histone lysine methyltransferase
histone-lysine N-methyltransferase SETD7
mastermind-like transcriptional coactivator 3, transcript variant X4
mastermind-like transcriptional coactivator 3, transcript variant X2
mastermind-like transcriptional coactivator 3, transcript variant X1
mastermind-like transcriptional coactivator 3, transcript variant X3
short coiled-coil protein, transcript variant X5
short coiled-coil protein, transcript variant X2
short coiled-coil protein, transcript variant X8
short coiled-coil protein, transcript variant X3
short coiled-coil protein, transcript variant X4
short coiled-coil protein, transcript variant X7
short coiled-coil protein, transcript variant X1
short coiled-coil protein, transcript variant X6
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ELMO/CED-12 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ELMO/CED-12 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ELMO/CED-12 domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ELMO/CED-12 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ELMO/CED-12 domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ELMO domain-containing protein 2 isoform X2
ELMO domain-containing protein 2 isoform X1
uncoupling protein 1, transcript variant X2
uncoupling protein 1, transcript variant X1
mitochondrial brown fat uncoupling protein 1 isoform X2
mitochondrial brown fat uncoupling protein 1 isoform X1
TBC1 domain family, member 9 (with GRAM domain)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ring finger protein 150a, transcript variant X2
ring finger protein 150a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
interleukin-15-like, transcript variant X10
interleukin-15-like, transcript variant X7
interleukin-15-like, transcript variant X5
interleukin-15-like, transcript variant X2
interleukin-15-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interleukin-15-like, transcript variant X6
interleukin-15-like, transcript variant X8
interleukin-15-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
interleukin-15-like, transcript variant X9
interleukin-15-like, transcript variant X4
uncharacterized protein LOC122539382 isoform X3
uncharacterized protein LOC122539382 isoform X2
inositol polyphosphate-4-phosphatase type II B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X5
inositol polyphosphate 4-phosphatase type II isoform X2
inositol polyphosphate-4-phosphatase type II B, transcript variant X4
inositol polyphosphate-4-phosphatase type II B, transcript variant X8
inositol polyphosphate-4-phosphatase type II B, transcript variant X1
inositol polyphosphate-4-phosphatase type II B, transcript variant X2
inositol polyphosphate-4-phosphatase type II B, transcript variant X3
inositol polyphosphate-4-phosphatase type II B, transcript variant X9
inositol polyphosphate-4-phosphatase type II B, transcript variant X10
inositol polyphosphate-4-phosphatase type II B, transcript variant X11
inositol polyphosphate-4-phosphatase type II B, transcript variant X12
inositol polyphosphate-4-phosphatase type II B, transcript variant X13
type II inositol 3,4-bisphosphate 4-phosphatase isoform X3
type II inositol 3,4-bisphosphate 4-phosphatase isoform X1
type II inositol 3,4-bisphosphate 4-phosphatase isoform X4
type II inositol 3,4-bisphosphate 4-phosphatase isoform X5
type II inositol 3,4-bisphosphate 4-phosphatase isoform X6
type II inositol 3,4-bisphosphate 4-phosphatase isoform X7
ubiquitin carboxyl-terminal hydrolase 38
GRB2-associated binding protein 1, transcript variant X1
GRB2-associated binding protein 1, transcript variant X2
GRB2-associated binding protein 1, transcript variant X5
GRB2-associated binding protein 1, transcript variant X3
GRB2-associated binding protein 1, transcript variant X4
GRB2-associated binding protein 1, transcript variant X6
GRB2-associated-binding protein 1 isoform X1
GRB2-associated-binding protein 1 isoform X2
GRB2-associated-binding protein 1 isoform X5
GRB2-associated-binding protein 1 isoform X3
GRB2-associated-binding protein 1 isoform X4
GRB2-associated-binding protein 1 isoform X6
membrane-associated progesterone receptor component 2-like
la-related protein 1B-like, transcript variant X3
la-related protein 1B-like, transcript variant X2
la-related protein 1B-like, transcript variant X1
la-related protein 1B-like, transcript variant X4
la-related protein 1B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
abhydrolase domain containing 18, transcript variant X2
abhydrolase domain containing 18, transcript variant X1
abhydrolase domain containing 18, transcript variant X4
abhydrolase domain containing 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122539390, transcript variant X3
uncharacterized LOC122539390, transcript variant X2
uncharacterized LOC122539390, transcript variant X1
major facilitator superfamily domain containing 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
major facilitator superfamily domain-containing protein 8
polo-like kinase 4 (Drosophila), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
polo-like kinase 4 (Drosophila), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase PLK4 isoform X2
serine/threonine-protein kinase PLK4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
ADP/ATP translocase 4-like, transcript variant X1
ADP/ATP translocase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inturned planar cell polarity protein, transcript variant X2
inturned planar cell polarity protein, transcript variant X3
inturned planar cell polarity protein, transcript variant X1
probable protein S-acyltransferase 23, transcript variant X2
probable protein S-acyltransferase 23, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable protein S-acyltransferase 23 isoform X2
probable protein S-acyltransferase 23 isoform X1
chromosome 32 C4orf33 homolog, transcript variant X7
chromosome 32 C4orf33 homolog, transcript variant X8
chromosome 32 C4orf33 homolog, transcript variant X6
chromosome 32 C4orf33 homolog, transcript variant X1
chromosome 32 C4orf33 homolog, transcript variant X2
chromosome 32 C4orf33 homolog, transcript variant X3
chromosome 32 C4orf33 homolog, transcript variant X4
chromosome 32 C4orf33 homolog, transcript variant X5
UPF0462 protein C4orf33 homolog isoform X2
UPF0462 protein C4orf33 homolog isoform X3
UPF0462 protein C4orf33 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
jade family PHD finger 1, transcript variant X5
jade family PHD finger 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
jade family PHD finger 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
jade family PHD finger 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
jade family PHD finger 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TBC1 domain family member 14-like, transcript variant X1
TBC1 domain family member 14-like isoform X1
TBC1 domain family member 14-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
TBC1 domain family member 14-like isoform X2
KIAA0232 ortholog, transcript variant X2
KIAA0232 ortholog, transcript variant X1
KIAA0232 ortholog, transcript variant X3
KIAA0232 ortholog, transcript variant X4
KIAA0232 ortholog, transcript variant X5
uncharacterized protein KIAA0232 homolog isoform X2
uncharacterized protein KIAA0232 homolog isoform X1
uncharacterized protein KIAA0232 homolog isoform X3
uncharacterized protein KIAA0232 homolog isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 340 Proteins
uncharacterized LOC122539409, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122539409 isoform X2
uncharacterized LOC122539409, transcript variant X1
uncharacterized protein LOC122539409 isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform isoform X5
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform isoform X4
Wolfram syndrome 1b (wolframin), transcript variant X2
Wolfram syndrome 1b (wolframin), transcript variant X3
Wolfram syndrome 1b (wolframin), transcript variant X1
Wolfram syndrome 1b (wolframin), transcript variant X4
golgin subfamily A member 6-like protein 22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule-interacting protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
janus kinase and microtubule-interacting protein 1-like, transcript variant X1
janus kinase and microtubule-interacting protein 1-like isoform X2
janus kinase and microtubule-interacting protein 1-like isoform X1
janus kinase and microtubule-interacting protein 1-like, transcript variant X3
janus kinase and microtubule-interacting protein 1-like isoform X3
dihydropyrimidinase-related protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dihydropyrimidinase-related protein 1-like isoform X1
dihydropyrimidinase-related protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dihydropyrimidinase-related protein 1-like isoform X2
ellis-van Creveld syndrome protein-like, transcript variant X2
ellis-van Creveld syndrome protein-like, transcript variant X1
ellis-van Creveld syndrome protein-like isoform X2
ellis-van Creveld syndrome protein-like isoform X1
ellis-van Creveld syndrome protein-like, transcript variant X4
ellis-van Creveld syndrome protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein kinase 32B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytokine-like protein 1, transcript variant X2
cytokine-like protein 1, transcript variant X1
leucine-rich repeat-containing protein 27-like, transcript variant X2
leucine-rich repeat-containing protein 27-like, transcript variant X1
leucine-rich repeat-containing protein 27-like isoform X1
leucine-rich repeat-containing protein 27-like, transcript variant X3
leucine-rich repeat-containing protein 27-like, transcript variant X4
leucine-rich repeat-containing protein 27-like isoform X3
uncharacterized protein LOC122539419 isoform X4
leucine-rich repeat-containing protein 27-like, transcript variant X5
uncharacterized protein LOC122539419 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
neuronal vesicle trafficking-associated protein 1-like, transcript variant X1
neuronal vesicle trafficking-associated protein 1-like, transcript variant X2
neuronal vesicle trafficking-associated protein 1-like
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 2 isoform X1
GPI ethanolamine phosphate transferase 2 isoform X3
GPI ethanolamine phosphate transferase 2 isoform X5
GPI ethanolamine phosphate transferase 2 isoform X2
phosphatidylinositol glycan anchor biosynthesis class G, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 2 isoform X4
hook microtubule-tethering protein 3, transcript variant X5
hook microtubule-tethering protein 3, transcript variant X7
hook microtubule-tethering protein 3, transcript variant X1
hook microtubule-tethering protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
hook microtubule-tethering protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
hook microtubule-tethering protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
hook microtubule-tethering protein 3, transcript variant X6
hook microtubule-tethering protein 3, transcript variant X8
hook microtubule-tethering protein 3, transcript variant X9
E3 ubiquitin-protein ligase RNF170-like, transcript variant X1
E3 ubiquitin-protein ligase RNF170-like, transcript variant X2
E3 ubiquitin-protein ligase RNF170-like, transcript variant X3
E3 ubiquitin-protein ligase RNF170-like, transcript variant X4
E3 ubiquitin-protein ligase RNF170-like, transcript variant X5
E3 ubiquitin-protein ligase RNF170-like isoform X1
E3 ubiquitin-protein ligase RNF170-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
THAP domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
THAP domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
THAP domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
THAP domain-containing protein 1-like isoform X2
THAP domain-containing protein 1-like isoform X1
THAP domain-containing protein 1-like isoform X3
RNA polymerase II subunit B, transcript variant X1
DNA-directed RNA polymerase II subunit RPB2 isoform X1
RNA polymerase II subunit B, transcript variant X2
DNA-directed RNA polymerase II subunit RPB2 isoform X2
insulin-like growth factor binding protein 7
insulin-like growth factor-binding protein 7
insulin-like growth factor-binding protein-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
thrombospondin type-1 domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC122539437, transcript variant X1
uncharacterized LOC122539437, transcript variant X3
uncharacterized LOC122539437, transcript variant X2
uncharacterized protein LOC122539437 isoform X1
uncharacterized protein LOC122539437 isoform X2
uncharacterized protein LOC122539437 isoform X3
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122539442, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122539442, transcript variant X1
uncharacterized LOC122539442, transcript variant X3
glycerol-3-phosphate acyltransferase 3, transcript variant X2
glycerol-3-phosphate acyltransferase 3, transcript variant X1
abraxas 1, BRCA1 A complex subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
abraxas 1, BRCA1 A complex subunit, transcript variant X1
BRCA1-A complex subunit Abraxas 1 isoform X1
BRCA1-A complex subunit Abraxas 1 isoform X2
28S ribosomal protein S18c, mitochondrial
helicase, POLQ like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
helicase, POLQ like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
helicase, POLQ like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
helicase, POLQ like, transcript variant X2
helicase, POLQ like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122539450, transcript variant X3
uncharacterized LOC122539450, transcript variant X1
uncharacterized LOC122539450, transcript variant X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
heparan-alpha-glucosaminide N-acetyltransferase
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
chondroitin sulfate N-acetylgalactosaminyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chondroitin sulfate N-acetylgalactosaminyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1-like
SH2 domain containing 4A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SH2 domain containing 4A, transcript variant X3
SH2 domain containing 4A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3-like, transcript variant X1
PH and SEC7 domain-containing protein 3-like, transcript variant X2
PH and SEC7 domain-containing protein 3-like isoform X1
PH and SEC7 domain-containing protein 3-like isoform X2
PH and SEC7 domain-containing protein 3-like, transcript variant X3
PH and SEC7 domain-containing protein 3-like isoform X3
fucosyltransferase 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fucosyltransferase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 10 isoform X2
alpha-(1,3)-fucosyltransferase 10 isoform X1
fucosyltransferase 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 10 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X5
pro-neuregulin-1, membrane-bound isoform isoform X4
pro-neuregulin-1, membrane-bound isoform isoform X2
pro-neuregulin-1, membrane-bound isoform isoform X3
pro-neuregulin-1, membrane-bound isoform isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63% coverage of the annotated genomic feature by RNAseq alignments
Werner syndrome ATP-dependent helicase homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
uncharacterized LOC122539464, transcript variant X3
uncharacterized LOC122539464, transcript variant X5
uncharacterized LOC122539464, transcript variant X7
uncharacterized LOC122539464, transcript variant X1
uncharacterized LOC122539464, transcript variant X4
uncharacterized LOC122539464, transcript variant X8
uncharacterized LOC122539464, transcript variant X6
uncharacterized LOC122539464, transcript variant X2
S-phase kinase-associated protein 1-like, transcript variant X2
S-phase kinase-associated protein 1-like, transcript variant X1
S-phase kinase-associated protein 1-like, transcript variant X3
S-phase kinase-associated protein 1-like
lymphoid enhancer-binding factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lymphoid enhancer-binding factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
lymphoid enhancer-binding factor 1, transcript variant X3
lymphoid enhancer-binding factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lymphoid enhancer-binding factor 1 isoform X1
lymphoid enhancer-binding factor 1 isoform X2
lymphoid enhancer-binding factor 1 isoform X3
lymphoid enhancer-binding factor 1 isoform X4
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phosphatidylcholine:ceramide cholinephosphotransferase 2
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
3'-phosphoadenosine 5'-phosphosulfate synthase 1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1
dickkopf WNT signaling pathway inhibitor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
aminoacyl tRNA synthetase complex interacting multifunctional protein 1a, transcript variant X3
aminoacyl tRNA synthetase complex interacting multifunctional protein 1a, transcript variant X1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1a, transcript variant X2
aminoacyl tRNA synthase complex-interacting multifunctional protein 1a isoform X1
aminoacyl tRNA synthase complex-interacting multifunctional protein 1a isoform X2
TBC1 domain containing kinase, transcript variant X2
TBC1 domain containing kinase, transcript variant X4
TBC1 domain containing kinase, transcript variant X6
TBC1 domain containing kinase, transcript variant X3
TBC1 domain containing kinase, transcript variant X1
TBC1 domain containing kinase, transcript variant X5
TBC domain-containing protein kinase-like protein isoform X1
TBC domain-containing protein kinase-like protein isoform X2
TBC domain-containing protein kinase-like protein isoform X3
glutathione S-transferase, C-terminal domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glutathione S-transferase, C-terminal domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutathione S-transferase, C-terminal domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutathione S-transferase C-terminal domain-containing protein
glutathione S-transferase, C-terminal domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase, Mg2+/Mn2+ dependent 1Kb, transcript variant X1
protein phosphatase, Mg2+/Mn2+ dependent 1Kb, transcript variant X3
protein phosphatase, Mg2+/Mn2+ dependent 1Kb, transcript variant X2
probable E3 ubiquitin-protein ligase HERC3, transcript variant X8
probable E3 ubiquitin-protein ligase HERC3, transcript variant X4
probable E3 ubiquitin-protein ligase HERC3, transcript variant X5
probable E3 ubiquitin-protein ligase HERC3, transcript variant X2
probable E3 ubiquitin-protein ligase HERC3, transcript variant X3
probable E3 ubiquitin-protein ligase HERC3, transcript variant X1
probable E3 ubiquitin-protein ligase HERC3, transcript variant X11
probable E3 ubiquitin-protein ligase HERC3, transcript variant X6
probable E3 ubiquitin-protein ligase HERC3 isoform X11
probable E3 ubiquitin-protein ligase HERC3 isoform X6
probable E3 ubiquitin-protein ligase HERC3 isoform X8
probable E3 ubiquitin-protein ligase HERC3 isoform X4
probable E3 ubiquitin-protein ligase HERC3 isoform X5
probable E3 ubiquitin-protein ligase HERC3 isoform X2
probable E3 ubiquitin-protein ligase HERC3 isoform X3
probable E3 ubiquitin-protein ligase HERC3 isoform X1
probable E3 ubiquitin-protein ligase HERC3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3 isoform X9
probable E3 ubiquitin-protein ligase HERC3 isoform X7
probable E3 ubiquitin-protein ligase HERC3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3 isoform X12
probable E3 ubiquitin-protein ligase HERC3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3, transcript variant X13
probable E3 ubiquitin-protein ligase HERC3, transcript variant X10
probable E3 ubiquitin-protein ligase HERC3 isoform X14
probable E3 ubiquitin-protein ligase HERC3 isoform X13
probable E3 ubiquitin-protein ligase HERC3 isoform X10
probable E3 ubiquitin-protein ligase HERC4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC4, transcript variant X4
probable E3 ubiquitin-protein ligase HERC4, transcript variant X2
probable E3 ubiquitin-protein ligase HERC4, transcript variant X1
probable E3 ubiquitin-protein ligase HERC4 isoform X3
probable E3 ubiquitin-protein ligase HERC4 isoform X2
probable E3 ubiquitin-protein ligase HERC4 isoform X1
probable E3 ubiquitin-protein ligase HERC3
probable E3 ubiquitin-protein ligase HERC4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
protein FAM13A-like, transcript variant X2
protein FAM13A-like, transcript variant X3
protein FAM13A-like, transcript variant X1
protein FAM13A-like, transcript variant X4
uncharacterized LOC122539485, transcript variant X4
uncharacterized LOC122539485, transcript variant X3
uncharacterized LOC122539485, transcript variant X2
uncharacterized LOC122539485, transcript variant X1
alpha-synuclein-like, transcript variant X2
alpha-synuclein-like, transcript variant X1
multimerin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
multimerin-1-like, transcript variant X2
multimerin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multimerin-1-like, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00096
coiled-coil serine-rich protein 1, transcript variant X1
coiled-coil serine-rich protein 1, transcript variant X2
coiled-coil serine-rich protein 1, transcript variant X5
coiled-coil serine-rich protein 1, transcript variant X4
coiled-coil serine-rich protein 1, transcript variant X6
coiled-coil serine-rich protein 1, transcript variant X7
coiled-coil serine-rich protein 1, transcript variant X9
coiled-coil serine-rich protein 1, transcript variant X8
serine-rich coiled-coil domain-containing protein 1 isoform X1
serine-rich coiled-coil domain-containing protein 1 isoform X2
serine-rich coiled-coil domain-containing protein 1 isoform X5
serine-rich coiled-coil domain-containing protein 1 isoform X8
serine-rich coiled-coil domain-containing protein 1 isoform X6
serine-rich coiled-coil domain-containing protein 1 isoform X7
coiled-coil serine-rich protein 1, transcript variant X3
serine-rich coiled-coil domain-containing protein 1 isoform X3
serine-rich coiled-coil domain-containing protein 1 isoform X4
glutamate receptor, ionotropic, delta 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor, ionotropic, delta 2, transcript variant X2
glutamate receptor ionotropic, delta-2 isoform X1
glutamate receptor ionotropic, delta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like isoform X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like, transcript variant X4
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like isoform X4
hematopoietic prostaglandin D synthase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hematopoietic prostaglandin D synthase-like, transcript variant X3
hematopoietic prostaglandin D synthase-like, transcript variant X1
hematopoietic prostaglandin D synthase-like isoform X2
hematopoietic prostaglandin D synthase-like isoform X1
PDZ and LIM domain 5a, transcript variant X3
PDZ and LIM domain 5a, transcript variant X4
PDZ and LIM domain 5a, transcript variant X1
PDZ and LIM domain 5a, transcript variant X9
PDZ and LIM domain 5a, transcript variant X11
PDZ and LIM domain 5a, transcript variant X14
PDZ and LIM domain 5a, transcript variant X5
PDZ and LIM domain 5a, transcript variant X6
PDZ and LIM domain 5a, transcript variant X7
PDZ and LIM domain 5a, transcript variant X8
PDZ and LIM domain 5a, transcript variant X10
PDZ and LIM domain 5a, transcript variant X12
PDZ and LIM domain 5a, transcript variant X13
PDZ and LIM domain 5a, transcript variant X2
PDZ and LIM domain protein 5a isoform X1
PDZ and LIM domain protein 5a isoform X6
PDZ and LIM domain protein 5a isoform X8
PDZ and LIM domain protein 5a isoform X11
PDZ and LIM domain protein 5a isoform X2
PDZ and LIM domain protein 5a isoform X3
PDZ and LIM domain protein 5a isoform X4
PDZ and LIM domain protein 5a isoform X5
PDZ and LIM domain protein 5a isoform X7
PDZ and LIM domain protein 5a isoform X9
PDZ and LIM domain protein 5a isoform X10
bone morphogenetic protein receptor, type IBa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor, type IBa, transcript variant X3
bone morphogenetic protein receptor, type IBa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bone morphogenetic protein receptor, type IBa, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein receptor type-1B isoform X1
bone morphogenetic protein receptor, type IBa, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bone morphogenetic protein receptor type-1B isoform X2
netrin receptor UNC5C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
netrin receptor UNC5C-like, transcript variant X4
netrin receptor UNC5C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
netrin receptor UNC5C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
netrin receptor UNC5C-like, transcript variant X5
sperm-tail PG-rich repeat containing 2, transcript variant X2
sperm-tail PG-rich repeat containing 2, transcript variant X1
sperm-tail PG-rich repeat-containing protein 2 isoform X2
sperm-tail PG-rich repeat-containing protein 2 isoform X1
sperm-tail PG-rich repeat containing 2, transcript variant X3
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X3
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X4
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X1
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X2
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X5
rap1 GTPase-GDP dissociation stimulator 1 isoform X1
rap1 GTPase-GDP dissociation stimulator 1 isoform X3
rap1 GTPase-GDP dissociation stimulator 1 isoform X4
rap1 GTPase-GDP dissociation stimulator 1 isoform X2
rap1 GTPase-GDP dissociation stimulator 1 isoform X5
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X6
RAP1, GTP-GDP dissociation stimulator 1, transcript variant X7
rap1 GTPase-GDP dissociation stimulator 1 isoform X6
eukaryotic translation initiation factor 4eb, transcript variant X2
eukaryotic translation initiation factor 4eb, transcript variant X1
eukaryotic translation initiation factor 4eb isoform X2
eukaryotic translation initiation factor 4eb isoform X1
alcohol dehydrogenase class-3, transcript variant X3
alcohol dehydrogenase class-3, transcript variant X1
alcohol dehydrogenase class-3, transcript variant X2
alcohol dehydrogenase class-3 isoform X3
alcohol dehydrogenase class-3 isoform X1
alcohol dehydrogenase class-3 isoform X2
tRNA methyltransferase 10A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tRNA methyltransferase 10A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
RNA (guanine-9-)-methyltransferase domain-containing protein 2
microsomal triglyceride transfer protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
microsomal triglyceride transfer protein large subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dual adaptor of phosphotyrosine and 3-phosphoinositides
dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, transcript variant X1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, transcript variant X2
DnaJ heat shock protein family (Hsp40) member B14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ATP-binding cassette, sub-family G (WHITE), member 2a
broad substrate specificity ATP-binding cassette transporter ABCG2
Rho guanine nucleotide exchange factor (GEF) 38, transcript variant X1
rho guanine nucleotide exchange factor 38 isoform X1
Rho guanine nucleotide exchange factor (GEF) 38, transcript variant X2
rho guanine nucleotide exchange factor 38 isoform X2
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like isoform X2
electrogenic sodium bicarbonate cotransporter 1-like isoform X1
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like isoform X4
electrogenic sodium bicarbonate cotransporter 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
RUN and FYVE domain containing 3, transcript variant X2
RUN and FYVE domain containing 3, transcript variant X1
RUN and FYVE domain containing 3, transcript variant X3
RUN and FYVE domain containing 3, transcript variant X4
RUN and FYVE domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RUN and FYVE domain containing 3, transcript variant X6
RUN and FYVE domain containing 3, transcript variant X7
RUN and FYVE domain containing 3, transcript variant X8
proepiregulin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proepiregulin-like, transcript variant X5
proepiregulin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
proepiregulin-like, transcript variant X4
proepiregulin-like, transcript variant X2
uncharacterized protein LOC122539528 isoform X2
prostate androgen-regulated mucin-like protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ring finger and CHY zinc finger domain containing 1
RING finger and CHY zinc finger domain-containing protein 1
glycine-rich cell wall structural protein 1.8-like, transcript variant X1
glycine-rich cell wall structural protein 1.8-like, transcript variant X2
glycine-rich cell wall structural protein 1.8-like isoform X1
glycine-rich cell wall structural protein 1.8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
G3BP stress granule assembly factor 2a, transcript variant X3
G3BP stress granule assembly factor 2a, transcript variant X2
G3BP stress granule assembly factor 2a, transcript variant X1
ras GTPase-activating protein-binding protein 2 isoform X3
ras GTPase-activating protein-binding protein 2 isoform X2
ras GTPase-activating protein-binding protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
general vesicular transport factor p115-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122539298, transcript variant X1
uncharacterized LOC122539298, transcript variant X2
broad substrate specificity ATP-binding cassette transporter ABCG2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
DNA damage-inducible transcript 4-like protein
uncharacterized LOC122539542, transcript variant X2
uncharacterized LOC122539542, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122539537 isoform X2
uncharacterized protein LOC122539537 isoform X4
uncharacterized protein LOC122539537 isoform X3
uncharacterized protein LOC122539537 isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X6
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
B-cell scaffold protein with ankyrin repeats-like, transcript variant X2
B-cell scaffold protein with ankyrin repeats-like, transcript variant X1
B-cell scaffold protein with ankyrin repeats-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
B-cell scaffold protein with ankyrin repeats-like, transcript variant X4
B-cell scaffold protein with ankyrin repeats-like isoform X1
B-cell scaffold protein with ankyrin repeats-like isoform X2
B-cell scaffold protein with ankyrin repeats-like isoform X4
B-cell scaffold protein with ankyrin repeats-like isoform X3
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X1
NACHT, LRR and PYD domains-containing protein 3-like isoform X2
NACHT, LRR and PYD domains-containing protein 3-like isoform X1
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X1
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X4
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X2
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X3
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X5
nuclear factor NF-kappa-B p105 subunit-like
mannosidase, beta A, lysosomal, transcript variant X4
mannosidase, beta A, lysosomal, transcript variant X2
mannosidase, beta A, lysosomal, transcript variant X1
mannosidase, beta A, lysosomal, transcript variant X6
mannosidase, beta A, lysosomal, transcript variant X3
mannosidase, beta A, lysosomal, transcript variant X5
ubiquitin-conjugating enzyme E2 D3, transcript variant X1
ubiquitin-conjugating enzyme E2 D3, transcript variant X2
ubiquitin-conjugating enzyme E2 D3 isoform X2
ubiquitin-conjugating enzyme E2 D3 isoform X1
CDGSH iron-sulfur domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122539300, transcript variant X2
uncharacterized LOC122539300, transcript variant X1
N-acetylneuraminic acid synthase a, transcript variant X2
N-acetylneuraminic acid synthase a, transcript variant X1
N-acetylneuraminic acid synthase a isoform X2
N-acetylneuraminic acid synthase a isoform X1
clathrin light chain A-like, transcript variant X2
clathrin light chain A-like, transcript variant X3
clathrin light chain A-like, transcript variant X1
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
solute carrier family 49 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 49 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 49 member 3, transcript variant X2
solute carrier family 49 member A3 isoform X1
solute carrier family 49 member A3 isoform X2
solute carrier family 49 member 3, transcript variant X3
solute carrier family 49 member A3 isoform X3
solute carrier family 49 member A3 isoform X4
uncharacterized protein LOC568697 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein si:ch211-175m2.5
small integral membrane protein 19, transcript variant X1
small integral membrane protein 19 isoform X1
small integral membrane protein 19, transcript variant X2
small integral membrane protein 19 isoform X2
signal recognition particle subunit SRP72
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cartilage intermediate layer protein 1 isoform X1
cartilage intermediate layer protein 1 isoform X2
mitochondrial methionyl-tRNA formyltransferase, transcript variant X2
mitochondrial methionyl-tRNA formyltransferase, transcript variant X1
methionyl-tRNA formyltransferase, mitochondrial isoform X2
methionyl-tRNA formyltransferase, mitochondrial isoform X1
AP-3 complex subunit sigma-2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 22 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
AP-3 complex subunit sigma-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
AP-3 complex subunit sigma-2, transcript variant X4
AP-3 complex subunit sigma-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
AP-3 complex subunit sigma-2, transcript variant X1
spermatogenesis-associated protein 5-like protein 1
sulfide quinone oxidoreductase, transcript variant X1
sulfide quinone oxidoreductase, transcript variant X2
sulfide:quinone oxidoreductase, mitochondrial
solute carrier family 30 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
solute carrier family 30 member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 30 member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 30 member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
normal mucosa of esophagus-specific gene 1 protein
uncharacterized LOC122539579, transcript variant X1
uncharacterized LOC122539579, transcript variant X2
signal peptide peptidase-like 2A, transcript variant X1
signal peptide peptidase-like 2A, transcript variant X2
signal peptide peptidase-like 2A, transcript variant X3
signal peptide peptidase-like 2A isoform X1
signal peptide peptidase-like 2A isoform X2
signal peptide peptidase-like 2A isoform X3
transient receptor potential cation channel, subfamily M, member 7
transient receptor potential cation channel subfamily M member 7
putative ubiquitin carboxyl-terminal hydrolase 50, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative ubiquitin carboxyl-terminal hydrolase 50 isoform X2
putative ubiquitin carboxyl-terminal hydrolase 50, transcript variant X1
putative ubiquitin carboxyl-terminal hydrolase 50 isoform X1
ubiquitin specific peptidase 8, transcript variant X2
ubiquitin specific peptidase 8, transcript variant X1
ubiquitin specific peptidase 8, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 8 isoform X2
ubiquitin carboxyl-terminal hydrolase 8 isoform X1
GA binding protein transcription factor subunit beta 1
very long-chain acyl-CoA synthetase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
glycine amidinotransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A
fibronectin type III and SPRY domain-containing protein 2, transcript variant X2
fibronectin type III and SPRY domain-containing protein 2, transcript variant X1
fibronectin type III and SPRY domain-containing protein 2
WASP homolog-associated protein with actin, membranes and microtubules
homer scaffold protein 2, transcript variant X2
homer scaffold protein 2, transcript variant X1
RNA guanine-N7 methyltransferase activating subunit-like
chromosome 32 C15orf40 homolog, transcript variant X2
chromosome 32 C15orf40 homolog, transcript variant X1
BTB/POZ domain-containing protein 1-like
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase
integrator complex subunit 14, transcript variant X2
integrator complex subunit 14, transcript variant X1
solute carrier family 24 member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 24 member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 24 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 24 member 1, transcript variant X2
sodium/potassium/calcium exchanger 1 isoform X1
sodium/potassium/calcium exchanger 1 isoform X4
sodium/potassium/calcium exchanger 1 isoform X2
sodium/potassium/calcium exchanger 1 isoform X3
DENN/MADD domain containing 4A, transcript variant X4
DENN/MADD domain containing 4A, transcript variant X7
DENN/MADD domain containing 4A, transcript variant X6
DENN/MADD domain containing 4A, transcript variant X8
DENN/MADD domain containing 4A, transcript variant X5
DENN/MADD domain containing 4A, transcript variant X1
DENN/MADD domain containing 4A, transcript variant X2
DENN/MADD domain containing 4A, transcript variant X3
DENN/MADD domain containing 4A, transcript variant X10
DENN/MADD domain containing 4A, transcript variant X9
C-myc promoter-binding protein isoform X8
C-myc promoter-binding protein isoform X5
C-myc promoter-binding protein isoform X4
C-myc promoter-binding protein isoform X6
C-myc promoter-binding protein isoform X7
C-myc promoter-binding protein isoform X3
C-myc promoter-binding protein isoform X2
C-myc promoter-binding protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
multiple epidermal growth factor-like domains protein 10